» Articles » PMID: 23227376

Genotype-Phenotype Characterization of Wolf-Hirschhorn Syndrome Confirmed by FISH: Case Reports

Overview
Journal Case Rep Genet
Publisher Wiley
Date 2012 Dec 11
PMID 23227376
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The Wolf-Hirschhorn syndrome (WHS) is a multiple malformation and contiguous gene syndrome resulting from the deletion encompassing a 4p16.3 region. A microscopically visible terminal deletion on chromosome 4p (4p16→pter) was detected in Case 1 with full blown features of WHS. The second case which had an interstitial microdeletion encompassing WHSC 1 and WHSC 2 genes at 4p16.3 presented with less striking clinical features of WHS and had an apparently "normal" karyotype. The severity of the clinical presentation was as a result of haploinsufficiency and interaction with surrounding genes as well as mutations in modifier genes located outside the WHSCR regions. The study emphasized that an individual with a strong clinical suspicion of chromosomal abnormality and a normal conventional cytogenetic study should be further investigated using molecular cytogenetic techniques such as fluorescence in situ hybridization (FISH) or array-comparative genomic hybridization (a-CGH).

Citing Articles

Genotype-phenotype correlation of deletions and duplications of 4p: case reports and literature review.

Zhang X, Lu H, Yang H, Ji Y, Liu H, Liu W Front Genet. 2023; 14:1174314.

PMID: 37388934 PMC: 10300434. DOI: 10.3389/fgene.2023.1174314.


Prenatal sonographic findings in confirmed cases of Wolf-Hirschhorn syndrome.

Simonini C, Hoopmann M, Kagan K, Schroder T, Gembruch U, Geipel A BMC Pregnancy Childbirth. 2022; 22(1):327.

PMID: 35428251 PMC: 9013087. DOI: 10.1186/s12884-022-04665-4.


Wolf-Hirschhorn Syndrome: Clinical and Genetic Study of 7 New Cases, and Mini Review.

Gavril E, Luca A, Curpan A, Popescu R, Resmerita I, Panzaru M Children (Basel). 2021; 8(9).

PMID: 34572183 PMC: 8471045. DOI: 10.3390/children8090751.


The Many Faces of : as a Model System to Study Wolf-Hirschhorn Syndrome.

Lasser M, Pratt B, Monahan C, Kim S, Lowery L Front Physiol. 2019; 10:817.

PMID: 31297068 PMC: 6607408. DOI: 10.3389/fphys.2019.00817.


Excellent response to levetiracetam in epilepsy with Wolf-Hirschhorn syndrome.

Karalok Z, Arhan E, Erdogan K, Gurkas E Childs Nerv Syst. 2015; 32(1):9-11.

PMID: 26590026 DOI: 10.1007/s00381-015-2967-0.


References
1.
South S, Bleyl S, Carey J . Two unique patients with novel microdeletions in 4p16.3 that exclude the WHS critical regions: implications for critical region designation. Am J Med Genet A. 2007; 143A(18):2137-42. DOI: 10.1002/ajmg.a.31900. View

2.
Wieczorek D, Krause M, Majewski F, Albrecht B, Meinecke P, Riess O . Unexpected high frequency of de novo unbalanced translocations in patients with Wolf-Hirschhorn syndrome (WHS). J Med Genet. 2001; 37(10):798-804. PMC: 1757157. DOI: 10.1136/jmg.37.10.798. View

3.
Rauch A, Schellmoser S, Kraus C, Dorr H, Trautmann U, Altherr M . First known microdeletion within the Wolf-Hirschhorn syndrome critical region refines genotype-phenotype correlation. Am J Med Genet. 2001; 99(4):338-42. DOI: 10.1002/ajmg.1203. View

4.
Wieczorek D, Krause M, Majewski F, Albrecht B, Horn D, Riess O . Effect of the size of the deletion and clinical manifestation in Wolf-Hirschhorn syndrome: analysis of 13 patients with a de novo deletion. Eur J Hum Genet. 2000; 8(7):519-26. DOI: 10.1038/sj.ejhg.5200498. View

5.
Battaglia A, Filippi T, Carey J . Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision. Am J Med Genet C Semin Med Genet. 2008; 148C(4):246-51. DOI: 10.1002/ajmg.c.30187. View